Pages that link to "Q37123874"
Jump to navigation
Jump to search
The following pages link to HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations (Q37123874):
Displaying 50 items.
- Molecular mechanisms of peritoneal dissemination in gastric cancer (Q26738538) (← links)
- Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents (Q26747054) (← links)
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (Q26747806) (← links)
- Intrinsic and Tumor Microenvironment-Induced Metabolism Adaptations of T Cells and Impact on Their Differentiation and Function (Q26749556) (← links)
- A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment (Q26749571) (← links)
- Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma (Q26752515) (← links)
- Role of multifaceted regulators in cancer glucose metabolism and their clinical significance (Q26765039) (← links)
- Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance (Q26765869) (← links)
- Hypoxia and Hypoxia-Inducible Factors in Leukemias (Q26767167) (← links)
- Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors (Q26768267) (← links)
- Diverse Mechanisms of Sp1-Dependent Transcriptional Regulation Potentially Involved in the Adaptive Response of Cancer Cells to Oxygen-Deficient Conditions (Q26771998) (← links)
- Hypoxia and metabolic adaptation of cancer cells (Q26774856) (← links)
- What controls the expression of the core-1 (Thomsen-Friedenreich) glycotope on tumor cells? (Q26779040) (← links)
- Cancer Metabolism and Drug Resistance (Q26782042) (← links)
- Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy (Q26783189) (← links)
- Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved? (Q26784413) (← links)
- Transcriptional regulation of chemokine expression in ovarian cancer (Q26825361) (← links)
- Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia? (Q26849504) (← links)
- Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? (Q26852282) (← links)
- Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response (Q27009437) (← links)
- Increasing Superoxide Production and the Labile Iron Pool in Tumor Cells may Sensitize Them to Extracellular Ascorbate (Q27021794) (← links)
- Hypoxia-independent drivers of melanoma angiogenesis (Q27022246) (← links)
- O-GlcNAcylation and Metabolic Reprograming in Cancer (Q27027028) (← links)
- Hypoxia-inducible aryl hydrocarbon receptor nuclear translocator (ARNT) (HIF-1β): is it a rare exception? (Q27027475) (← links)
- PPP2R5C Couples Hepatic Glucose and Lipid Homeostasis (Q27310235) (← links)
- Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion (Q27329571) (← links)
- Structural integration in hypoxia-inducible factors (Q27701731) (← links)
- Glioblastoma, hypoxia and autophagy: a survival-prone 'ménage-à-trois' (Q28067399) (← links)
- Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma (Q28067482) (← links)
- The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy (Q28067724) (← links)
- Mechanisms underlying 18F-fluorodeoxyglucose accumulation in colorectal cancer (Q28067736) (← links)
- Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy (Q28069398) (← links)
- Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts (Q28078990) (← links)
- Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer (Q28079155) (← links)
- Adipose tissue dysfunction and its effects on tumor metabolism (Q28080748) (← links)
- mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging (Q28081442) (← links)
- Mechanisms involved in breast cancer liver metastasis (Q28084024) (← links)
- 2-Hydoxyglutarate: D/Riving Pathology in gLiomaS (Q28087807) (← links)
- Progress and prospects of reactive oxygen species in metal carcinogenesis (Q28388934) (← links)
- Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system (Q28389419) (← links)
- miR-190 Enhances HIF-Dependent Responses to Hypoxia in Drosophila by Inhibiting the Prolyl-4-hydroxylase Fatiga (Q28395196) (← links)
- A synthetic manassantin a derivative inhibits hypoxia-inducible factor 1 and tumor growth (Q28539658) (← links)
- Modulation of membrane lipid composition and homeostasis in salmon hepatocytes exposed to hypoxia and perfluorooctane sulfonamide, given singly or in combination (Q28540958) (← links)
- The histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibition (Q28542639) (← links)
- Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines (Q28553394) (← links)
- Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming (Q28771755) (← links)
- Deubiquitinases (DUBs) and DUB inhibitors: a patent review (Q28834608) (← links)
- Renal cell carcinoma (Q30235364) (← links)
- VHL-dependent alterations in the secretome of renal cell carcinoma: Association with immune cell response? (Q30316025) (← links)
- Enhancing the evaluation of PI3K inhibitors through 3D melanoma models (Q30746265) (← links)